Skip to main content
. 2021 Jul 20;11:687564. doi: 10.3389/fonc.2021.687564

Table 4.

Analysis of adverse events.

Adverse Events Grade 1 or 2 (n,%) Grade 3 or 4 (n,%) Total (n,%)
Hypertension 1 (5) 4 (20) 5 (25)
Rash 1 (5) 0 (0) 1 (5)
Hand-foot skin reaction 3 (15) 1 (5) 4 (20)
Mouth ulcers 1 (5) 1 (5) 2 (10)
Thrombocytopenia 1 (5) 0 (0) 1 (5)
Increase in liver enzymes 1 (5) 0 (0) 1 (5)
Increase intriglycerides 1 (5) 0 (0) 1 (5)
Cerebral infarction 0 1 (5) 1 (5)